RALEIGH, N.C., June 5, 2017 /Weed Wire/ – U.S. Senator Thom Tillis (R-NC) recently co-sponsored the Cannabidiol Research Expansion Act, a bill to support research initiatives on the potential benefits of substances such as cannabidiol (CBD) that are derived from marijuana.
Tag Archives: Dianne Feinstein
On May 25, 2017, Sens. Dianne Feinstein, D-Calif., and Chuck Grassley, R-Iowa, announced that they had introduced the Cannabidiol Research Expansion Act, a bill that would ask the Attorney General to reconsider whether cannabidiol should be scheduled under the Controlled Substances Act and expand research opportunities as a means of determining the medical efficacy of cannabidiol and marijuana in the treatment of serious medical conditions.
WASHINGTON, May 25, 2017 /Weed Wire/ — Senators Dianne Feinstein (D-Calif.) and Chuck Grassley (R-Iowa), leaders of the Senate Caucus on International Narcotics Control, today introduced the Cannabidiol Research Expansion Act, a bill to support research initiatives on the potential benefits of substances such as cannabidiol (CBD) that are derived from marijuana.
In a statement sent to Senate offices today the Drug Policy Alliance urged the Senate Judiciary Committee to reject Jeff Sessions for Attorney General. The committee is holding confirmation hearings on Sessions on Tuesday and Wednesday.
WASHINGTON, July 18, 2016 /Weed Wire/ — Today, the Cannabidiol Research Expansion Act (S. 3269) was introduced in the United States Senate, which would ease research barriers and create exemptions from federal law for certain medical cannabis patients.
An amendment protecting state medical marijuana programs from federal meddling passed the Senate Appropriations Committee by a vote of 21-9. Of those 9 “nays,” only one was from a Democrat—U.S. Senator Dianne Feinstein from California. The Drug Policy Alliance hopes to sway the legislator’s opinion.